Search for: "Barre v. Hoffman"
Results 1 - 20
of 23
Sorted by Relevance
|
Sort by Date
13 Apr 2020, 4:32 am
Barr by Geoffrey Hoffman, Clinical Professor, University of Houston Law Center I was moved this morning to write about a recent decision from the Fifth Circuit. [read post]
26 Jan 2010, 9:59 pm
Hoffman-La Roche Ltd., Pfizer, Inc. v. [read post]
31 Jan 2011, 8:10 am
Barr Laboratories, Inc. 93 USPQ 2d 1417 (Fed. [read post]
31 Jan 2011, 8:10 am
Barr Laboratories, Inc. 93 USPQ 2d 1417 (Fed. [read post]
14 Nov 2007, 8:59 pm
Actavis Boniva: Hoffman-LaRoche v. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges… [read post]
27 Aug 2012, 11:01 am
Hoffman La-Roche Ltd., 580 F.3d 1340 (Fed. [read post]
5 Dec 2008, 1:00 pm
FDA issues draft guidance on submission of patent information for certain old antibiotics (FDA Law Blog) US: FDA publishes new guidance on contents of a complete submission for the evaluation of proprietary names (FDA Law Blog) USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360)… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
10 Nov 2010, 1:11 am
Becton-Dickinson (Patent Docs) US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) US: BIO and AUTM fire back at gene patent foes – AMP v USPTO (Patent Baristas) (Patent Docs) US: IPO files amicus brief in AMP v USPTO (Patent Docs) (Patent Baristas) US: AIPLA submits amicus brief in AMP v USPTO (Patent Docs) US: Summary of… [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
12 Feb 2009, 10:42 am
Hoffman-La Roche, Inc., 618 N.W.2d 827, 837 (Neb. 2000); Bish v. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
8 May 2008, 12:22 pm
Hoffman-LaRoche, Inc., 949 F.2d 806 (5th Cir. 1992). [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
18 Feb 2010, 10:34 am
” Id.; accord Heckler v. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
